Home/Filings/4/0001104659-14-012353
4//SEC Filing

CONCERT PHARMACEUTICALS, INC. 4

Accession 0001104659-14-012353

CIK 0001367920operating

Filed

Feb 20, 7:00 PM ET

Accepted

Feb 21, 5:46 PM ET

Size

20.6 KB

Accession

0001104659-14-012353

Insider Transaction Report

Form 4
Period: 2014-02-20
Transactions
  • Conversion

    Common Stock

    2014-02-20+106,1941,058,920 total(indirect: See Footnote)
  • Purchase

    Common Stock

    2014-02-20$14.00/sh+150,000$2,100,0001,208,920 total(indirect: See Footnote)
  • Conversion

    Series A Convertible Preferred Stock

    2014-02-202,200,0000 total(indirect: See Footnote)
    Common Stock (389,380 underlying)
  • Conversion

    Common Stock

    2014-02-20+389,380421,752 total(indirect: See Footnote)
  • Conversion

    Series C Convertible Preferred Stock

    2014-02-20600,0000 total(indirect: See Footnote)
    Common Stock (106,194 underlying)
  • Conversion

    Common Stock

    2014-02-20+530,974952,726 total(indirect: See Footnote)
  • Conversion

    Series B Convertible Preferred Stock

    2014-02-203,000,0000 total(indirect: See Footnote)
    Common Stock (530,974 underlying)
Footnotes (3)
  • [F1]The Series A, Series B and Series C Convertible Preferred Stock converted into Common Stock on a 1-for-5.65 basis upon the closing of the issuer's initial public offering without payment of consideration.
  • [F2]Held by Skyline Venture Partners Qualified Purchaser Fund IV L.P. Dr. John G. Freund and Dr. Yasunori Kaneko are Managing Members of Skyline Venture Management IV, LLC, which is the sole general partner of Skyline Venture Partners Qualified Purchaser Fund IV, L.P., and as such may be deemed to share voting and dispositive power with respect to all shares held by Skyline Venture Partners Qualified Purchaser Fund IV, L.P. Drs. Freund and Kaneko disclaim beneficial ownership of such shares except to the extent of their pecuniary interest therein. Dr. Freund is a director of the Issuer and, accordingly, files separate Section 16 reports.
  • [F3]Not applicable.

Documents

1 file

Issuer

CONCERT PHARMACEUTICALS, INC.

CIK 0001367920

Entity typeoperating

Related Parties

1
  • filerCIK 0001367920

Filing Metadata

Form type
4
Filed
Feb 20, 7:00 PM ET
Accepted
Feb 21, 5:46 PM ET
Size
20.6 KB